Tenaya Therapeutics, Inc.
TNYA
$2.12
$0.104.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.41% | -20.10% | -11.91% | -4.65% | 0.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.88% | -16.39% | -11.62% | -8.60% | -5.74% |
| Operating Income | 18.88% | 16.39% | 11.62% | 8.60% | 5.74% |
| Income Before Tax | 17.49% | 15.10% | 10.44% | 8.18% | 6.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.49% | 15.10% | 10.44% | 8.18% | 6.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.49% | 15.10% | 10.44% | 8.18% | 6.56% |
| EBIT | 18.88% | 16.39% | 11.62% | 8.60% | 5.74% |
| EBITDA | 20.51% | 17.77% | 12.27% | 9.14% | 6.21% |
| EPS Basic | 37.59% | 29.60% | 22.00% | 23.59% | 31.15% |
| Normalized Basic EPS | 37.59% | 29.61% | 22.02% | 23.60% | 31.16% |
| EPS Diluted | 37.43% | 29.45% | 21.85% | 23.45% | 31.15% |
| Normalized Diluted EPS | 37.59% | 29.61% | 22.02% | 23.60% | 31.16% |
| Average Basic Shares Outstanding | 41.47% | 21.74% | 15.19% | 18.60% | 29.45% |
| Average Diluted Shares Outstanding | 41.47% | 21.74% | 15.19% | 18.60% | 29.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |